L934-0423 Screening compound: N-{5-[1-(4-ethoxyphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-oxadiazol-2-yl}-4-methoxybenzamide

L934-0423 Screening compound: N-{5-[1-(4-ethoxyphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-oxadiazol-2-yl}-4-methoxybenzamide
L934-0423 Screening compound: N-{5-[1-(4-ethoxyphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-oxadiazol-2-yl}-4-methoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L934-0423
N-{5-[1-(4-ethoxyphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-oxadiazol-2-yl}-4-methoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L934-0423

Molecular Formula

C22H22N4O5 (C22 H22 N4 O5)

Compound Name

N-{5-[1-(4-ethoxyphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-oxadiazol-2-yl}-4-methoxybenzamide

IUPAC name

N-{5-[1-(4-ethoxyphenyl)-5-oxopyrrolidin-3-yl]-134-oxadiazol-2-yl}-4-methoxybenzamide

SMILES

CCOc(cc1)ccc1N(CC(C1)c2nnc(NC(c(cc3)ccc3OC)=O)o2)C1=O

InChI

InChI=1S/C22H22N4O5/c1-3-30-18-10-6-16(7-11-18)26-13-15(12-19(26)27)21-24-25-22(31-21)23-20(28)14-4-8-17(29-2)9-5-14/h4-11,15H,3,12-13H2,1-2H3,(H,23,25,28)/t15-/m1/s1

InChI Key

IZHWWKZLSNGIFK-OAHLLOKOSA-N

MDL Number (MFCD)

MFCD27488369

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

422.44

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.354

Distribution Coefficient, logD

0.994

Water Solubility, LogSw

-2.83

Polar Surface Area

86.575

Acid Dissociation Constant (pKa)

6.06

Base Dissociation Constant (pKb)

-1.37

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

27.30

L934-0423 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L934-0423 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L934-0423?
Check Price and Availability of L934-0423, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L934-0423 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L934-0423
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L934-0423
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L934-0423 available by request